-
1
Real-world ePRO use and clinical outcomes using electronic patient-reported symptom monitoring for patients with advanced non-small-cell lung cancer receiving first-line pembrolizu...
Published 2025-01-01“…Journal of Comparative Effectiveness Research…”
Article -
2
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy
Published 2025-01-01“…Journal of Comparative Effectiveness Research…”
Article -
3
The burden of Alagille syndrome: uncovering the potential of emerging therapeutics – a comprehensive systematic literature review
Published 2025-01-01“…Journal of Comparative Effectiveness Research…”
Article -
4
A real-world analysis of antidepressant medications in US veterans aged 60 years and older: a comparative analysis
Published 2025-01-01“…Journal of Comparative Effectiveness Research…”
Article -
5
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China
Published 2024-12-01“…Journal of Comparative Effectiveness Research…”
Article -
6
Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain
Published 2025-01-01“…Journal of Comparative Effectiveness Research…”
Article -
7
Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative cl...
Published 2025-01-01“…Journal of Comparative Effectiveness Research…”
Article -
8
Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema
Published 2025-01-01“…Journal of Comparative Effectiveness Research…”
Article